Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Lavakumar (Kumar) Karyampudi, Senior Director of Cell Therapies at Moffitt Cancer Center, to discuss how academic institutions are evolving to meet the demands of early-phase CGT trials. Kumar shares how Moffitt is building flexible, end-to-end infrastructure that supports the full development cycle – from translational research to GMP manufacturing. Together, they explore how tighter integration between scientists, clinicians, and operational teams can accelerate first-in-human trials, why academic centres play a crucial role in advancing CGTs, and how the right partnerships can extend institutional capabilities. Connect with Kumar:

You can listen to Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success online on Radio and Podcast. Open the player on this page to stream the available audio.

Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success is an episode from Ori Spotlight by Ori Biotech.

This episode is 01:00:07 long.

This episode was published on Aug 12, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Ori Spotlight when more episodes are available from the podcast feed.